Inhibition of lipopolysaccharide-induced gene expression by liver X receptor ligands in macrophages involves interference with early growth response factor 1

Prostaglandins, Leukotrienes, and Essential Fatty Acids
Paloma Guillem-Llobat, Miguel A Iñiguez

Abstract

Liver X receptors (LXRs) are nuclear receptors that act as ligand-dependent transcription factors forming permissive heterodimers with retinoid X receptors (RXRs). In this study we aimed to assess the effect of LXR/RXR activation on the transcriptional induction of pro-inflammatory genes including cyclooxygenase-2 (COX-2) and microsomal prostaglandin E2 synthase-1 (mPGES-1) in activated macrophages. Our study shows that LXR ligands such as oxysterols, GW3965 or TO901317, as well as RXR ligands like 9cis retinoic acid or SR11237, decreased LPS-induced expression of COX-2 and mPGES-1. Consequently, LPS-dependent PGE2 production was substantially reduced in macrophages treated with LXR/RXR ligands. The inhibitory effects of LXR/RXR activation on LPS-induced expression of COX-2 and mPGES-1 in macrophages, occurred by a mechanism involving interference with transcriptional activation of these genes. LXR/RXR activation interfered with the activity of transcription factors essential in the up-regulation of the expression of pro-inflammatory genes in these cells, such as NFκB, but also Egr-1, which had not been previously associated with LXR-mediated gene repression. As this transcription factor is involved in the regulation of a varie...Continue Reading

References

Mar 1, 1992·Genes & Development·D J MangelsdorfR M Evans
May 1, 1995·Genes & Development·P J WillyD J Mangelsdorf
Dec 15, 1995·Cell·D J Mangelsdorf, R M Evans
Feb 29, 2000·The Journal of Biological Chemistry·D J WadleighH R Herschman
Mar 11, 2000·The Journal of Clinical Investigation·T A McCaffreyT Collins
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·A VenkateswaranP Tontonoz
Nov 23, 2000·Genes & Development·J R SchultzB Shan
Jul 19, 2001·The Journal of Biological Chemistry·T T LuD J Mangelsdorf
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sean B JosephPeter Tontonoz
Oct 18, 2002·Journal of Cellular Physiology·Gerald Thiel, Giuseppe Cibelli
Jan 14, 2003·Nature Medicine·Sean B JosephPeter Tontonoz
Jan 18, 2003·The Journal of Biological Chemistry·Antonio CastrilloPeter Tontonoz
Apr 12, 2003·Molecular Endocrinology·Peter Tontonoz, David J Mangelsdorf
Aug 20, 2004·Pharmacological Reviews·Daniel L SimmonsTimothy Hla
Mar 9, 2005·The FEBS Journal·Naoki TerasakaToshihiko Fujiwara
Feb 4, 2006·Circulation Research·Levon M Khachigian
Mar 3, 2006·The Journal of Clinical Investigation·Noam Zelcer, Peter Tontonoz
Sep 1, 2006·The Journal of Biological Chemistry·Chaitra MaratheAntonio Castrillo
Oct 31, 2006·Oncogene·M S HaydenS Ghosh
Sep 20, 2007·Pharmacological Reviews·Bengt SamuelssonPer-Johan Jakobsson
Feb 19, 2008·The Journal of Biological Chemistry·Elke HoffmannMichael Kracht
Apr 16, 2011·Circulation Research·Seung-Soon Im, Timothy F Osborne
Jan 20, 2012·Journal of Digestive Diseases·Yuan LiuXiong Ma
May 1, 2012·Trends in Pharmacological Sciences·Tomas JakobssonKnut R Steffensen
Jun 7, 2013·Expert Opinion on Therapeutic Targets·Knut R SteffensenJan-Åke Gustafsson
May 17, 2014·Nature Reviews. Drug Discovery·Cynthia Hong, Peter Tontonoz

❮ Previous
Next ❯

Citations

Jan 21, 2019·Molecular and Cellular Endocrinology·Liqian Ma, Erik R Nelson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.